|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-8-8
|
|
pubmed:abstractText |
Recent large epidemiologic population-based studies identified gamma-glutamyltransferase (GGT) as a marker for increased cervical cancer incidence. Furthermore, high levels of GGT seem to increase the risk of progression of high-grade cervical dysplasia to invasive carcinoma. Therefore, we evaluated the association between pre-therapeutic serum GGT levels, tumor stage and prognosis in patients with cervical cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1095-6859
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
122
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
590-4
|
|
pubmed:meshHeading |
pubmed-meshheading:21664662-Apoptosis,
pubmed-meshheading:21664662-Female,
pubmed-meshheading:21664662-Humans,
pubmed-meshheading:21664662-Middle Aged,
pubmed-meshheading:21664662-Neoplasm Staging,
pubmed-meshheading:21664662-Prognosis,
pubmed-meshheading:21664662-Survival Analysis,
pubmed-meshheading:21664662-Tumor Markers, Biological,
pubmed-meshheading:21664662-Uterine Cervical Neoplasms,
pubmed-meshheading:21664662-gamma-Glutamyltransferase
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. polteras@mskcc.org
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
